Home > About Telesso > The Personnel

Mr Ian Atkin

Chief Financial Executive & Company Secretary

Mr Atkin is a Chartered Accountant and Partner in Kidmans Chartered Accountants and brings with him experience in business and financial management.

Dr Doug McTaggart

Non Executive Director

Dr. Doug McTaggart has extensive management, consulting and academic experience to include roles as Under Treasurer and Under Secretary, Queensland Treasury. In that capacity, Doug served as a Director of QIC. Currently, he serves as CEO of the Queensland Investment Corporation (QIC), a $70B investment fund.

Directorships: QInvest, Investment and Financial Services Association, Queensland BioCapital Funds Pty Ltd., and Telesso Technologies.

Trustee Committee for Economic Development of Australia. Member of Council, Queensland University of Technology. Councillor, National Competition Council. Governor of the Queensland Community Foundation.

 

Dr Peter C. Farrell, PhD, AM

Non Executive Director

Dr. Farrell has served as a company director since May 2008. He is founding Chairman and was Chief Executive Officer of Resmed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep disordered breathing.

Dr. Farrell holds bachelor and masters degrees in chemical engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in bioengineering from the University of Washington, Seattle and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.

 

Dr Ross Macdonald

Non-executive Director

Dr Macdonald is Vice President Business Development for Connetics Corporation, a specialty pharmaceutical company based in Palo Alto, California with a focus on the development and commercialisation of innovative therapeutics for the dermatology market. Before joining Connetics he was Vice President of Research & Development with FH Faulding & Co Limited (now part of Mayne Group Limited) and a former Managing Director of Soltec Research.

Dr Macdonald began as a consultant research analyst in the pharmaceutical industry before joining AMRAD Corporation in 1987, where he held various positions in business development.

Mr Michael Hoy

Non Executive Director and Chairman

Mr Hoy is a businessman and company director with extensive corporate experience in Australia, the UK, USA and Asia. He is chairman of Biotron Limited; chairman of Cityprint Holdings Pty Limited; and a former director of John Fairfax Holdings Limited and FX Trust Limited.

Mr Hoy is appointed to the Board as a representative of Jagen Pty Limited

Mr Lawrence Gozlan

Non Executive Director

Mr Gozlan is the CEO and founder of Scientia Capital, a specialised global investment fund focused exclusively in life sciences.

Prior to this, Mr Gozlan was responsible for the largest biotechnology portfolio in Australia as the institutional biotechnology analyst at QIC, a funds manager with over $50 billion under management. He was also the senior biotechnology sell-side analyst in the equities team at Foster Stockbroking, and has had senior corporate finance experience advising life science companies at Deloitte